WeightWatchers stock rallies 170%! But new compounded GLP-1 drug is 'not a sustainable long-term business model.'

By Yahoo! Finance | Oct 10, 2024 at 05:36 PM EST

WeightWatchers is venturing into the weight-loss drug market to revitalize its struggling business, with a recent surge in stock value. By offering compounded GLP-1 drugs, the company aims to compete with giants like Novo Nordisk and Eli Lilly, despite potential challenges ahead.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.